Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis

Published:2019-01 Issue:1 Volume:15 Page:129-141
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Chen Yichao,Sun Jingjing,Huang Yixian,Liu Yanhua,Liang Lei,Yang Da,Lu Binfeng,Li Song

Funder

National Institute of Health

Shear Family Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference59 articles.

1. A perspective on cancer cell metastasis;Chaffer;Science,2011

2. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation;Liotta;Cell,1991

3. Metastasis: Dissemination and growth of cancer cells in metastatic sites;Chambers;Nat Rev Cancer,2002

4. Genes that mediate breast cancer metastasis to lung;Minn;Nature,2005

5. Lung metastases from melanoma: when is surgical treatment warranted?;Leo;Br J Cancer,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells;Cellular Signalling;2024-05

2. Codelivery of Doxorubicin and p53 Gene by β-Cyclodextrin-Based Supramolecular Nanoparticles Formed via Host–Guest Complexation and Electrostatic Interaction;Biomacromolecules;2024-04-08

3. Application of nanoformulations as a strategy to optimize chemotherapeutic treatment of glioblastoma: a systematic review;Journal of Toxicology and Environmental Health, Part B;2024-03-13

4. Advances and applications of nanoparticles in cancer therapy;MedComm – Oncology;2024-03

5. Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles;ACS Materials Au;2023-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3